Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:2
作者
Hadinia, Abolghasem [1 ]
Doustimotlagh, Amir Hossein [2 ,3 ]
Goodarzi, Hamed Reza [1 ]
Arya, Arash [4 ]
Jafarinia, Mojtaba [1 ]
机构
[1] Islamic Azad Univ, Marvdasht Branch, Dept Genet, Marvdasht, Iran
[2] Yasuj Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Yasuj, Iran
[3] Yasuj Univ Med Sci, Fac Med, Dept Clin Biochem, Yasuj, Iran
[4] Yasuj Univ Med Sci, Internal Med, Yasuj, Iran
关键词
Interleukin-1; beta; Interleukin-6; Non-Alcoholic Fatty Liver; Non-Alcoholic Steatohepatitis; Tumor Necrosis Factor-alpha; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; FACTOR-ALPHA; OXIDATIVE STRESS; FOLLOW-UP; ADIPOKINES; NASH; PROGRESSION;
D O I
10.22034/iji.2019.80284
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pro-inflammatory cytokines are associated with systemic inflammatory responses. Objective: To investigate the levels of pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha) in patients with non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) compared to healthy individuals. Methods: This case-control study was conducted on 30 patients with NAFL, 30 patients with NASH, and 30 healthy volunteers. The plasma level of IL-1 beta, IL-6, and TNF-alpha were determined by ELISA, and biochemical parameters were measured using colorimetric methods. Results: IL-1 beta and IL-6 levels were significantly higher in patients with NASH compared with NAFL and control group. However, TNF-alpha levels had no significant variations in NAFL and NASH patients compared to the control group (p=0.903 and p=0.960, respectively). Conclusion: Results showed that the levels of ALT activity and pro-inflammatory cytokines were higher in patients with NASH compared to control and NAFL subjects; Therefore, steatosis and inflammation develop as a result of excessive pro-inflammatory factors in NASH.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [21] Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Yamamura, Sakura
    Nakano, Dan
    Hashida, Ryuki
    Tsutsumi, Tsubasa
    Kawaguchi, Takumi
    Okada, Michiaki
    Isoda, Hiroshi
    Takahashi, Hirokazu
    Matsuse, Hiroo
    Eguchi, Yuichiro
    Sumida, Yoshio
    Nakajima, Atsushi
    Gerber, Lynn
    Younossi, Zobair M.
    Torimura, Takuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (03) : 629 - 636
  • [22] Liver and serum adiponectin levels in non-alcoholic fatty liver disease
    Mavilia, Marianna G.
    Wu, George Y.
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (04) : 214 - 221
  • [23] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246
  • [24] Circulating microRNAs in patients with non-alcoholic fatty liver disease
    Serkan Dogan
    Gokmen Zararsiz
    Sebnem Gursoy
    Kadri Guven
    Omer Ozbakir
    Munis Dundar
    Mehmet Yucesoy
    World Journal of Hepatology, 2014, 6 (08) : 613 - 620
  • [25] Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
    Niikura, Toshihiro
    Imajo, Kento
    Ozaki, Anna
    Kobayashi, Takashi
    Iwaki, Michihiro
    Honda, Yasushi
    Kessoku, Takaomi
    Ogawa, Yuji
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Nakajima, Atsushi
    DIAGNOSTICS, 2020, 10 (03)
  • [26] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [27] SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
    Novo, Erica
    Cappon, Andrea
    Villano, Gianmarco
    Quarta, Santina
    Cannito, Stefania
    Bocca, Claudia
    Turato, Cristian
    Guido, Maria
    Maggiora, Marina
    Protopapa, Francesca
    Sutti, Salvatore
    Provera, Alessia
    Ruvoletto, Mariagrazia
    Biasiolo, Alessandra
    Foglia, Beatrice
    Albano, Emanuele
    Pontisso, Patrizia
    Parola, Maurizio
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Circulating microRNAs in patients with non-alcoholic fatty liver disease
    Celikbilek, Mehmet
    Baskol, Mevlut
    Taheri, Serpil
    Deniz, Kemal
    Dogan, Serkan
    Zararsiz, Gokmen
    Gursoy, Sebnem
    Guven, Kadri
    Ozbakir, Omer
    Dundar, Munis
    Yucesoy, Mehmet
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (08) : 613 - 620
  • [29] Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells
    Zhang, Feng
    Jiang, Wei Wei
    Li, Xia
    Qiu, Xin Yun
    Wu, Zhe
    Chi, Yu Jing
    Cong, Xu
    Liu, Yu Lan
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (07) : 464 - 474
  • [30] Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
    Smirne, Carlo
    Mulas, Violante
    Barbaglia, Matteo Nazzareno
    Mallela, Venkata Ramana
    Minisini, Rosalba
    Barizzone, Nadia
    Burlone, Michela Emma
    Pirisi, Mario
    Grossini, Elena
    DIAGNOSTICS, 2020, 10 (12)